Caffeine + Nalt Capsules 200/230 mg
Single ingredient · 180 servings · $30.99 · 4.3 stars from 704 reviews
Worth trying for Focus
Probably helps: attention
- Evidence Worth trying
- Dose 1 of 1 at a studied dose
- Safety Read the label's warnings
- Fillers None of concern
What's in it
The one active we can check reaches a studied dose.
Supplement Facts
Serving Size: 1 Capsule(s)
180 per container
- N-Acetyl L-Tyrosine 230 mg †
- Caffeine Probably helps · Sharper focus › 200 mg †
† Daily Value not established
Other ingredients: Microcrystalline Cellulose, Stearic Acid, Cellulose.
Suggested Use: As a dietary supplement, take 1 capsule daily.
Doses against the trials
-

Caffeine
At the studied dose
200 mg a day studies used 60–800 mg · 70 studies
1 more on the label with no studied dose or Daily Value to check against.
Worth knowing
The label's warnings
Disclaimer: Always consult with a qualified health physician before taking any new dietary supplement.
Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, or if you have any known or suspected medical condition, and/or taking prescription drug(s) or OTC medications(s).
This product contains pure caffeine and can be dangerous if abused. Always follow suggested usage and use accordingly when consuming on a daily basis. Failure to follow safety guidelines can result in injury or death!
Medicines its ingredients can clash with
Antihypertensives, Antidepressants, Other, Carbamazepine, Phenobarbital, Phenytoin, Gabapentin, Levetiracetam
Reported side effects
Death, Seizure, Rhabdomyolysis, Myocardial infarction, Arrhythmia, Hepatotoxicity
The other ingredients
Clean formula. The inactive ingredients are standard capsule components.
- Microcrystalline Cellulose: bulking agent
- Stearic Acid: flow agent; fine in trace
- Cellulose: bulking agent
Nootropics Depot
87 out of 100
Brand audit score
Nootropics Depot documents quality-control and testing transparency, but the available records do not establish quality across its product range.





